Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Hiroshi Ueoka

1-50 of 69 results

View this query on the Wikidata Query Service
The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

scientific article published in February 2005
Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer

scientific article
Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer

scientific article published in November 2004
Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.

scientific article published on 7 June 2010
Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer.

scientific article published in February 2005
Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials

scientific article
Phase II trial of gefitinib in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer with activating EGFR gene mutations: the Okayama Lung Cancer Study Group Trial 1001.

scientific article published in March 2015
Thrombocytosis as a useful prognostic indicator in patients with lung cancer

scientific article published in March 2004
Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung cancer: the Okayama Lung Cancer Study Group experience

scientific article published in February 2010
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study Group

scientific article
Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells

scientific article published on 8 August 2003
Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin

scientific article published on 23 June 2005
Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer

scientific article
Recent improvement in the survival of patients with advanced nonsmall cell lung cancer enrolled in phase III trials of first-line, systemic chemotherapy

scientific article published on March 2007
Dramatic effect of ZD1839 ('Iressa') in a patient with advanced non-small-cell lung cancer and poor performance status

scientific article published in April 2003
Aberrant promoter hypermethylation in serum DNA from patients with silicosis

scientific article published on 16 July 2008
Comparison of chemosensitivity tests: clonogenic assay versus MTT assay

scientific article published in June 2002
Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy

scientific article published in March 2002
Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma

scientific article published on 5 November 2004
An overview of 48 elderly-specific clinical trials of systemic chemotherapy for advanced non-small cell lung cancer

scientific article published in October 2004
Determinants of cisplatin and irinotecan activities in human lung adenocarcinoma cells: evidence of cisplatin accumulation and topoisomerase I activity

scientific article published on July 2005
Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experience

scientific article
Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion

scientific article published in May 2007
A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

scientific article
A Randomized Phase II Study of a Combination of Docetaxel and S-1 versus Docetaxel Monotherapy in Patients with Non-small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy: Results of Okayama Lung Cancer Study Group (OLCSG) Trial 0

Impact of HER2 gene and protein status on the treatment outcome of cisplatin-based chemoradiotherapy for locally advanced non-small cell lung cancer

scientific article published in May 2008
Benefits and Adverse Events Among Elderly Patients Receiving Concurrent Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: Analysis of the Okayama Lung Cancer Study Group Trial 0007

article
Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.

scientific article published in May 2003
A phase II study of S-1 chemotherapy with concurrent thoracic radiotherapy in elderly patients with locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0801.

scientific article
Gefitinib induces premature senescence in non-small cell lung cancer cells with or without EGFR gene mutation.

scientific article published on February 2007
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patients

scientific article published on 4 May 2004
A phase I study and pharmacokinetics of irinotecan (CPT-11) and paclitaxel in patients with advanced non-small cell lung cancer

scientific article
Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line

scientific article published on November 2004
A phase II study of amrubicin and topotecan combination therapy in patients with relapsed or extensive-disease small-cell lung cancer: Okayama Lung Cancer Study Group Trial 0401.

scientific article published on 18 February 2011
Gefitinib should be cautiously administered to poor performance status patients with non-small-cell lung cancer: results from a prospective feasibility study

scientific article
A phase II study of cisplatin plus S-1 with concurrent thoracic radiotherapy for locally advanced non-small-cell lung cancer: the Okayama Lung Cancer Study Group Trial 0501.

scientific article published on 8 November 2014
Association of the benefit from gefitinib monotherapy with smoking status in Japanese patients with non-small-cell lung cancer

scientific article published on 15 May 2008
Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage small-cell lung cancer

scientific article
Association between poor performance status and risk for toxicity during erlotinib monotherapy in Japanese patients with non-small cell lung cancer: Okayama Lung Cancer Study Group experience

scientific article published on 22 April 2010
A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer

scientific article
Recent improvement in lung cancer screening: a comparison of the results carried out in two different time periods

scientific article published in June 2006
The combination effect of amrubicin with cisplatin or irinotecan for small-cell lung cancer cells.

scientific article published on April 2006
Cisplatin down-regulates topoisomerase I activity in lung cancer cell lines.

scientific article published on November 2004
Risk of neutropenic fever and early infectious complications after autologous peripheral blood stem cell transplantation for malignant diseases

scientific article published on August 2002
Daily low-dose cisplatin and concurrent thoracic irradiation for poor-risk patients with unresectable non-small-cell lung cancer

scientific article published in October 2002
A phase I and pharmacological study of amrubicin and topotecan in patients of small-cell lung cancer with relapsed or extensive-disease small-cell lung cancer

scientific article
Advances in our understanding of postoperative adjuvant chemotherapy in resectable non-small-cell lung cancer

scientific article
A phase II study of topotecan and cisplatin with sequential thoracic radiotherapy in elderly patients with small-cell lung cancer: Okayama Lung Cancer Study Group 0102.

scientific article
Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer

scientific article published on February 1, 2010
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancer.

scientific article

Paulina is supported by:

About Paulina

Help